✦ LIBER ✦

A phase II trial of Paclitaxel, Carboplatin and Gemcitabine (Taxcarbogem) in the treatment of stage III non small cell lung cancer (NSCLC). Toxicity profile

✍ Scribed by Almenarez, J; Murias, A; Garcia, I; Molano, F; Aguiar, J; Bohn, U; Camacho, M.C; Lopez, L; Rodriguez, J; Cabrera, L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel and carboplatin in combinatio

✍ Favaretto, A; Paccagnella, A; Tumolo, S; Barbieri, F; Ceresoli, G; Gulisano, M; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Paclitaxel and carboplatin in combinatio

✍ Ceresoli, G.L; Favaretto, A; Paccagnella, A; Barbieri, F; Bearz, A; Schiavon, A. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Preoperative treatment with paclitaxel a

✍ De Candis, D; Stani, S.C; Bidoli, P; Potepan, P; Bedini, V.A; Cataldo, I; Michet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

1173 PUBLICATION Phase II trial of neo-a

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

O-094 Paclitaxel and gemcitabine vs carb

✍ Kosmidis, P.; Kalofonos, C.; Syrigos, K.; Skarlos, D.; Fountzilas, G.; Nicolaide 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

PD-084 Phase II trial of gemcitabine-car

✍ Abratt, R.; Lee, J.; Han, J.; Tsai, C.; Boyer, M.; Mok, T.; Kim, S.; Lee, J.; Br 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB